Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanlin Hu

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Annals of Surgical Oncology|January 24, 2020
Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of LifeYiran Si, Peng Yuan, Nanlin Hu, et al.
International Journal of Nanomedicine|March 12, 2021
Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast CancerYiran Si, Jian Yue, Zhaoyang Liu, et al.
Cancer Biology & Medicine|March 12, 2021
Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancerNanlin Hu, Yiran Si, Jian Yue, et al.
Cancer Immunology, Immunotherapy : CII|August 2, 2024
Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seqYan Tian, Chao Liu, Wenhui Yang, et al.
Frontiers in Oncology|October 26, 2020
<i>ABTB2</i> Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast CancerYajie Gong, Nanlin Hu, Li Ma, et al.
Cancer Biology & Medicine|May 26, 2021
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNAAnjie Zhu, Peng Yuan, Nanlin Hu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Annals of Surgical Oncology|January 24, 2020
Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of LifeYiran Si, Peng Yuan, Nanlin Hu, et al.
International Journal of Nanomedicine|March 12, 2021
Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast CancerYiran Si, Jian Yue, Zhaoyang Liu, et al.
Cancer Biology & Medicine|March 12, 2021
Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancerNanlin Hu, Yiran Si, Jian Yue, et al.
Cancer Immunology, Immunotherapy : CII|August 2, 2024
Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seqYan Tian, Chao Liu, Wenhui Yang, et al.
Frontiers in Oncology|October 26, 2020
<i>ABTB2</i> Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast CancerYajie Gong, Nanlin Hu, Li Ma, et al.
Cancer Biology & Medicine|May 26, 2021
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNAAnjie Zhu, Peng Yuan, Nanlin Hu, et al.
Pageof 2